Literature DB >> 2483551

Cellular components of subretinal membranes in proliferative vitreoretinopathy.

P Hiscott1, I Morino, R Alexander, I Grierson, Z Gregor.   

Abstract

To determine the cellular composition of subretinal membranes in proliferative vitreoretinopathy, surgically excised membranes were studied using electron microscopic and immunohistochemical procedures. Light microscopic immunohistochemistry was found to be superior to conventional electron microscopy as a means of evaluating the relative contributions of retinal pigment epithelium and glia to subretinal membranes. The cells of subretinal membranes chiefly comprised retinal pigment epithelium while glial cells were either absent or contributed only a minor component. It is proposed that the clinical properties of subretinal membranes in proliferative vitreoretinopathy derive from their retinal pigment epithelial cell element.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2483551     DOI: 10.1038/eye.1989.94

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  8 in total

Review 1.  Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.

Authors:  D G Charteris
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

2.  Immunohistochemical characterization of surgically removed subfoveal fibrovascular membranes.

Authors:  S Seregard; P V Algvere; L Berglin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-06       Impact factor: 3.117

3.  Fibronectin synthesis in subretinal membranes of proliferative vitreoretinopathy.

Authors:  P Hiscott; H A Waller; I Grierson; M G Butler; D L Scott; Z Gregor; I Morino
Journal:  Br J Ophthalmol       Date:  1992-08       Impact factor: 4.638

4.  The pathology of abortive neovascular outgrowths from the retina.

Authors:  P Hiscott; R J Cooling; P Rosen; A Garner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

5.  Resveratrol inhibits transforming growth factor-β2-induced epithelial-to-mesenchymal transition in human retinal pigment epithelial cells by suppressing the Smad pathway.

Authors:  Ching-Long Chen; Yi-Hao Chen; Ming-Cheng Tai; Chang-Min Liang; Da-Wen Lu; Jiann-Torng Chen
Journal:  Drug Des Devel Ther       Date:  2017-01-11       Impact factor: 4.162

6.  P38 inhibition reverses TGFβ1 and TNFα-induced contraction in a model of proliferative vitreoretinopathy.

Authors:  Lauren Schiff; Nathan C Boles; Marie Fernandes; Bar Nachmani; Ronald Gentile; Timothy A Blenkinsop
Journal:  Commun Biol       Date:  2019-05-03

7.  Clinical Features and Surgical Treatment of Subretinal Proliferation in Proliferative Diabetic Retinopathy.

Authors:  Chan Wu; Rongping Dai; Youxin Chen; Xiao Zhang; Zhe Chen
Journal:  Front Med (Lausanne)       Date:  2022-02-11

8.  Müller glia as an important source of cytokines and inflammatory factors present in the gliotic retina during proliferative vitreoretinopathy.

Authors:  K Eastlake; P J Banerjee; A Angbohang; D G Charteris; P T Khaw; G A Limb
Journal:  Glia       Date:  2015-11-10       Impact factor: 7.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.